According to Avalon Pharma (Middle East Pharmaceutical)'s latest financial reports the company's current earnings are โฌ0.13 Billion. In 2025 the company made an earning of โฌ25.42 Million, an increase over its 2024 earnings that were of โฌ21.32 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.